By continuing to use our site, you agree to our Terms of Use and Privacy Policy. You can learn more about how we use cookies by reviewing our Privacy Policy.

I Agree

About Lori Lawley, CPA:

Lori Lawley is the Chief Financial Officer of Lumos Pharma. She brings over ten years of experience and accounting expertise in overseeing financial operations, including over five years of public company senior management experience in biotechnology. Prior to the merger with Lumos Pharma, she held various senior roles of increasing responsibility in NewLink’s finance department, including Corporate Controller, Director Financial and SEC Reporting, and most recently as Vice President of Finance and Controller and member of the Office of the CEO. As a member of the senior management team, she assisted in the development and execution of the corporate strategy, financial planning, and communications with key external stakeholders.

Ms. Lawley has over eight years of public accounting experience at Ernst & Young where she was a Senior Manager in Assurance Services. There, Ms. Lawley oversaw teams through the planning and completion of integrated and non-integrated audits of financial statements within both the public and private sectors.

Ms. Lawley is a licensed certified public accountant. She earned a BBA in Accounting and a master’s degree in Professional Accounting from The University of Texas at Austin, Red McCombs School of Business.